IL101537A - OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST - Google Patents

OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST

Info

Publication number
IL101537A
IL101537A IL101537A IL10153792A IL101537A IL 101537 A IL101537 A IL 101537A IL 101537 A IL101537 A IL 101537A IL 10153792 A IL10153792 A IL 10153792A IL 101537 A IL101537 A IL 101537A
Authority
IL
Israel
Prior art keywords
combinations
carbonic anhydrase
anhydrase inhibitor
adrenergic antagonist
ophthalmic compositions
Prior art date
Application number
IL101537A
Other languages
English (en)
Other versions
IL101537A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27103852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL101537(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL101537A0 publication Critical patent/IL101537A0/xx
Publication of IL101537A publication Critical patent/IL101537A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL101537A 1991-04-17 1992-04-09 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST IL101537A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68671891A 1991-04-17 1991-04-17
US83491392A 1992-02-13 1992-02-13

Publications (2)

Publication Number Publication Date
IL101537A0 IL101537A0 (en) 1992-12-30
IL101537A true IL101537A (en) 1997-11-20

Family

ID=27103852

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101537A IL101537A (en) 1991-04-17 1992-04-09 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST

Country Status (25)

Country Link
EP (1) EP0509752B1 (ja)
JP (1) JP2527513B2 (ja)
KR (1) KR920019348A (ja)
CN (1) CN1073421C (ja)
AT (1) ATE182787T1 (ja)
AU (1) AU648659C (ja)
CA (1) CA2065965C (ja)
CH (1) CH0509752H1 (ja)
CY (1) CY2146B1 (ja)
CZ (1) CZ285129B6 (ja)
DE (3) DE10075002I2 (ja)
DK (1) DK0509752T3 (ja)
ES (1) ES2133304T3 (ja)
GR (1) GR3031467T3 (ja)
HK (1) HK1009251A1 (ja)
IE (1) IE921240A1 (ja)
IL (1) IL101537A (ja)
LU (1) LU90506I2 (ja)
MX (1) MX9201785A (ja)
NL (1) NL990041I2 (ja)
NO (1) NO306196B1 (ja)
RO (1) RO113612B1 (ja)
SK (1) SK282039B6 (ja)
WO (1) WO1992018124A1 (ja)
YU (1) YU39392A (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
AU677577B2 (en) * 1992-02-21 1997-05-01 Alcon Laboratories, Inc. Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
FI981473A (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
CN100345594C (zh) * 2004-01-19 2007-10-31 无锡杰西医药科技有限公司 乙酰唑胺滴眼液
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
PT2598118T (pt) 2010-07-29 2018-11-29 Allergan Inc Soluções de bimatoprost e timolol isentas de conservantes
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
JP5893204B1 (ja) * 2015-02-23 2016-03-23 参天製薬株式会社 防腐効果のある医薬の組合せ
TW201726127A (zh) * 2016-01-29 2017-08-01 參天製藥股份有限公司 含有多佐胺、高分子及硼酸之醫藥組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use

Also Published As

Publication number Publication date
DE69229688T4 (de) 2010-08-19
NL990041I1 (nl) 2000-02-01
CN1066781A (zh) 1992-12-09
DK0509752T3 (da) 1999-12-06
ATE182787T1 (de) 1999-08-15
WO1992018124A1 (en) 1992-10-29
CY2146B1 (en) 2002-06-21
NO306196B1 (no) 1999-10-04
LU90506I2 (fr) 2000-03-28
SK282039B6 (sk) 2001-10-08
EP0509752A2 (en) 1992-10-21
KR920019348A (ko) 1992-11-19
IL101537A0 (en) 1992-12-30
NO933714D0 (no) 1993-10-15
YU39392A (sh) 1995-12-04
CN1073421C (zh) 2001-10-24
MX9201785A (es) 1992-10-01
HK1009251A1 (en) 1999-05-28
CZ209893A3 (en) 1994-06-15
AU648659B2 (en) 1994-04-28
GR3031467T3 (en) 2000-01-31
DE10075002I1 (de) 2000-03-30
CZ285129B6 (cs) 1999-05-12
IE921240A1 (en) 1992-10-21
NL990041I2 (nl) 2000-04-03
DE10075002I2 (de) 2004-07-01
ES2133304T3 (es) 1999-09-16
NO933714L (no) 1993-10-15
EP0509752A3 (en) 1993-03-03
EP0509752B1 (en) 1999-08-04
CA2065965A1 (en) 1992-10-18
AU648659C (en) 2008-02-14
DE69229688D1 (de) 1999-09-09
AU1497992A (en) 1992-10-22
CH0509752H1 (ja) 2012-11-30
DE69229688T2 (de) 2000-02-24
RO113612B1 (ro) 1998-09-30
DE69229688C5 (de) 2010-10-21
SK110393A3 (en) 1994-02-02
JP2527513B2 (ja) 1996-08-28
JPH05117167A (ja) 1993-05-14
CA2065965C (en) 1998-06-16

Similar Documents

Publication Publication Date Title
EP0253094A3 (en) Use of prostaglandin d2-active substances in the treatment of ocular hypertension and glaucoma
CA2110844A1 (en) Pupil-tuned multifocal ophthalmic lens
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
IL101537A (en) OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST
IL97426A0 (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
EP0815868A4 (en) A CHINESE DRUG COMPOSITION FOR THE TREATMENT OF STOMULIC Ulcers AND THE PRODUCTION THEREOF
IL108784A0 (en) Use of 2h-1,2,4-benzothiadiazin-3(4h)-one 1,1-dioxide derivatives as noncompetitive antagonists of the mmda receptor
ITMI911998A1 (it) Dispositivo abradente agglomerato particolarmente per burattatura e simili nonche' procedimento realizzativo.
ATE98647T1 (de) Substituierte thieno(2,3-b) thiophen-2sulfonamide als mittel gegen glaukoma.
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DE3462220D1 (en) Use of d,l and d-carazolole for the manufacture of antiglaucoma agents and pharmaceutical compositions containing d-carazolole
HK1111636A1 (en) Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension
EP0309028A3 (en) Substituted thieno(2,3-b)furan-2-sulfonamides as antiglaucoma agents
AU3039492A (en) The use of n'-substituted n-phenylsulphonylureas in the treatment of hypertension in insulin-resistant subjects
IT9020366A0 (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
IT220425Z2 (it) Involucro protettivo per padelle e simili, particolarmente studiato per l'impiego in ambito ospedialiero
IT9021076A0 (it) "nuovo uso del bendazac e dei suoi sali farmaceuticamente accettabili"
IT1225800B (it) Polarizzatore doppio, per l'osservazione dei cinescopi in genere

Legal Events

Date Code Title Description
NP Permission for amending the patent specification granted (section 66, patents law 1967)
NP Permission for amending the patent specification granted (section 66, patents law 1967)
EXTP Application for extension order is pending
EXTP Application for extension order is pending
FF Patent granted
KB Patent renewed
EXTN Extension order renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired